|
neuromuscular junction disease
|
DOID_439 |
|
|
ovarian mucinous cystadenocarcinoma
|
DOID_3604 |
|
|
ovarian mucinous adenocarcinoma
|
DOID_3606 |
|
|
anti-HIV-2 agent
|
CHEBI_64949 |
|
|
anti-HIV agent
|
CHEBI_64946 |
|
|
appendix adenocarcinoma
|
DOID_3608 |
|
|
appendix carcinoma
|
DOID_4902 |
|
|
ureter carcinoma
|
DOID_4939 |
|
|
ureter cancer
|
DOID_11819 |
|
|
sideramine
|
CHEBI_26671 |
|
|
siderophore
|
CHEBI_26672 |
|
|
iron ionophore
|
CHEBI_24874 |
|
|
iron(3+) chelator
|
CHEBI_24028 |
|
|
EC 3.4.21.1 (chymotrypsin) inhibitor
|
CHEBI_64943 |
|
|
EC 3.6.4.* (hydrolases acting on ATP; involved in cellular and subcellular movement) inhibitor
|
CHEBI_76938 |
|
|
ampulla of Vater carcinoma
|
DOID_4932 |
|
|
ampulla of Vater cancer
|
DOID_10020 |
|
|
EC 6.4.* (C-C bond-forming ligase) inhibitor
|
CHEBI_75604 |
|
|
La Crosse encephalitis
|
DOID_0050118 |
|
|
EC 6.5.* (phosphoric ester bond-forming ligase) inhibitor
|
CHEBI_75605 |
|
